| __timestamp | Intra-Cellular Therapies, Inc. | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 13673000 |
| Thursday, January 1, 2015 | 87718074 | 14358000 |
| Friday, January 1, 2016 | 93831530 | 12203000 |
| Sunday, January 1, 2017 | 79419009 | 18125000 |
| Monday, January 1, 2018 | 132166913 | 17071000 |
| Tuesday, January 1, 2019 | 89124838 | 20018000 |
| Wednesday, January 1, 2020 | 65782137 | 32788000 |
| Friday, January 1, 2021 | 88845513 | 44966000 |
| Saturday, January 1, 2022 | 134715000 | 311681000 |
| Sunday, January 1, 2023 | 180142000 | 77707000 |
Infusing magic into the data realm
In the competitive landscape of pharmaceuticals and biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Intra-Cellular Therapies, Inc. and Lantheus Holdings, Inc. have shown distinct strategies in their R&D allocations over the past decade.
From 2014 to 2023, Intra-Cellular Therapies, Inc. has consistently increased its R&D expenses, peaking in 2023 with a 750% increase from 2014. This upward trend underscores their aggressive pursuit of new therapies and innovations.
Conversely, Lantheus Holdings, Inc. experienced a significant spike in 2022, with R&D expenses surging by over 2,200% compared to 2014. This dramatic rise highlights a strategic pivot towards enhancing their product pipeline.
Both companies exemplify the dynamic nature of R&D investment, reflecting their unique approaches to growth and innovation in the healthcare sector.
Research and Development Investment: Zoetis Inc. vs Intra-Cellular Therapies, Inc.
Research and Development: Comparing Key Metrics for Alnylam Pharmaceuticals, Inc. and Lantheus Holdings, Inc.
Research and Development Investment: Genmab A/S vs Intra-Cellular Therapies, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Opthea Limited
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amicus Therapeutics, Inc.
Intra-Cellular Therapies, Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc.
Lantheus Holdings, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Lantheus Holdings, Inc. and Catalyst Pharmaceuticals, Inc.
R&D Spending Showdown: Lantheus Holdings, Inc. vs MiMedx Group, Inc.